DR. SIN MIN MELVYN YEOH D.M.D., M.D.
Prescription History 1992964795
Oral & Maxillofacial Surgery in Lexington, KY


Quality Rating: 100 out of 100 score

NPI Status: Active since June 06, 2008

Contact Information

UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY
800 ROSE STREET, ROOM D104
LEXINGTON, KY
ZIP 40536
Phone: (859) 323-9707
Fax: (859) 323-5858

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SIN MIN MELVYN YEOH D.M.D., M.D., an active Oral & Maxillofacial Surgery specialist practicing in Lexington, KY. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 87 documented patient claims. Among these therapy options, the most frequently utilized medication is Chlorhexidine Gluconate, which accounts for 37 claims alone.

Medication Index


Alprazolam

Generic Formulation: AlprazolamSpecialty: Maxillofacial Surgery
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
KY State Average Benchmarks
Peer Average Claims81.0
Peer Average 30-Day Fills85.0
Peer Average Days Supply2,384
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.4% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $150.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.72

State Avg Cost Per Claim

$9.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)

Therapeutic Applications

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Amoxicillin-Clavulanate Potass

Generic Formulation: Amoxicillin/Potassium ClavSpecialty: Maxillofacial Surgery
Provider Metrics Summary
Total Claims 18
30-Day Fills 20.0
Days Supply 309
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.3
Peer Average Days Supply255
Conservative Utilization

This provider writes prescriptions for this formulation 35.7% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $163.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.08

State Avg Cost Per Claim

$11.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.

Therapeutic Applications

Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Chlorhexidine Gluconate

Generic Formulation: Chlorhexidine GluconateSpecialty: Maxillofacial Surgery
Provider Metrics Summary
Total Claims 37
30-Day Fills 37.1
Days Supply 585
KY State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills42.1
Peer Average Days Supply776
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $190.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.16

State Avg Cost Per Claim

$5.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria in the mouth, helping to reduce swelling and redness of the gums and bleeding when you brush.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Maxillofacial Surgery
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 189
KY State Average Benchmarks
Peer Average Claims147.0
Peer Average 30-Day Fills148.0
Peer Average Days Supply3,431
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 85.7% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $234.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.15

State Avg Cost Per Claim

$22.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SIN MIN MELVYN YEOH D.M.D., M.D. provides transparency into local medical care patterns within Lexington, KY.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Oral & Maxillofacial Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.